According to Cai et al., compared with levels in the healthy control, liver fibrosis, and CHB groups, the serum HMGB1 levels of ACLF patients are significantly increased, suggesting that HMGB1 can provide diagnostic or prognostic information for HBV-related ACLF (58). This evidence concerns the gene HMGB1 and Hepatic fibrosis.